castle trial patient story
Chronic Disease Management vs CAR‑T 2026 Will Change?
In 2024, CAR-T therapies achieved a 70% remission rate in the CASTLE trial, showing that chronic disease management will be reshaped by CAR-T advances in 2026. Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health